Precision Optics Corp Inc (POCI)
6.23
0.00 (0.00%)
USD |
NASDAQ |
Jul 03, 16:00
Precision Optics Research and Development Expense (Annual): 0.9924M for June 30, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| June 30, 2023 | 0.9924M |
| June 30, 2022 | 0.6665M |
| June 30, 2021 | 0.6243M |
| June 30, 2020 | 0.8861M |
| June 30, 2019 | 0.5053M |
| June 30, 2018 | 0.4564M |
| June 30, 2017 | 0.4642M |
| June 30, 2016 | 0.4783M |
| June 30, 2015 | 0.4929M |
| June 30, 2014 | 0.4711M |
| June 30, 2013 | 0.6303M |
| June 30, 2012 | 0.6647M |
| June 30, 2011 | 0.825M |
| Date | Value |
|---|---|
| June 30, 2010 | 0.5294M |
| June 30, 2009 | 0.7378M |
| June 30, 2008 | 0.7579M |
| June 30, 2007 | 1.312M |
| June 30, 2006 | 1.106M |
| June 30, 2005 | 1.143M |
| June 30, 2004 | 1.319M |
| June 30, 2003 | 1.235M |
| June 30, 2002 | 2.271M |
| June 30, 2001 | 3.215M |
| June 30, 2000 | 1.694M |
| June 30, 1999 | 0.90M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
0.6243M
Minimum
2021
0.9924M
Maximum
2023
0.7923M
Average
0.7763M
Median
Research and Development Expense (Annual) Benchmarks
| AptarGroup Inc | -- |
| Daxor Corp | -- |
| Sanara MedTech Inc | 4.132M |
| Warby Parker Inc | -- |
| Perspective Therapeutics Inc | 21.31M |